GHB (Gamma-hydroxybutyrate)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: GHB (Gamma-Hydroxybutyrate) — Dual Scheduling (Schedule I Illicit/Schedule III as Xyrem), Drug-Facilitated Sexual Assault, Narrow Therapeutic Index, Alcohol Synergy, DFSA Detection Window, and Physical Dependence with Withdrawal (2022) REGULATORY · 2022
• US FDA: Sodium Oxybate (Xyrem/Lumryz) — Narcolepsy Approval, REMS Program for Abuse Mitigation, Pediatric Indication (Age 7+ Years), and GHB Chemical Identity with Illicit GHB (2022) REGULATORY · 2022
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID2074740 (GHB (Gamma-hydroxybutyrate)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.